Hims Stock at $50: Here's What Truist Expects Next
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Despite the controversy, the stock has staged an impressive rebound, with shares up 108% year-to-date and now hovering around $50. The rally has been driven by strong quarterly results and growing momentum in the company's weight-loss offerings.
Looking ahead, all eyes now turn to the company's upcoming Q2 earnings report, slated for August 4. Truist analyst Jailendra Singh expects results to land mostly in line with expectations, noting that current forecasts already reflect the high end of HIMS' guidance. He projects revenue of $549.4 million and adjusted EBITDA of $74.4 million, closely aligned with Street consensus and the company's provided range.
However, Singh also flags some cautionary signals. The analyst anticipates a slight dip in online revenue per subscriber compared to Q1, attributing it to seasonal trends and reduced reliance on commercially available Semaglutide. Q1's outperformance, after all, benefited from one-off drivers like the Super Bowl ad and the initial buzz around HIMS-branded weight-loss offerings.
That brings up the bigger question: where does HIMS go from here in the second half of the year? While some investors worry about a potential guidance cut following the Novo fallout, others are optimistic about a lift tied to the recent acquisition of European telemedicine provider Zava. Singh, for his part, remains cautious. The analyst believes a 2H ramp may be difficult unless Zava or other acquisitions begin to meaningfully contribute. Still, he doesn't expect management to revise guidance just yet, preferring to wait and assess the impact of new initiatives in Q3.
As for upcoming developments to watch, Singh cites updates on a possible lawsuit from Novo Nordisk (which would be negative), new product launches in testosterone and menopause treatments (positive), and further M&A activity (also positive).
'From additional M&A point of view, a transaction giving the company entry into the employer/payor market will be transformational and has potential to change the narrative,' Singh further said.
What to Do with HIMS Stock Now?
Singh is sticking with a Hold (i.e., Neutral) rating, nudging his price target up from $45 to $48, which still suggests ~5% downside from where the stock is currently trading. (To watch Singh's track record, click here)
And he's not alone in that cautious stance. The broader analyst community is mostly on the sidelines too, with 7 Holds, 2 Sells, and just 1 Buy – all coalescing to a Hold consensus rating. Based on the average price target of $41.78, the Street sees the stock pulling back by 17% over the next year. (See HIMS stock forecast)
To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
PHINIA Inc. Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
PHINIA Inc. (NYSE:PHIN) defied analyst predictions to release its quarterly results, which were ahead of market expectations. PHINIA beat earnings, with revenues hitting US$890m, ahead of expectations, and statutory earnings per share outperforming analyst reckonings by a solid 15%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on PHINIA after the latest results. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Taking into account the latest results, PHINIA's five analysts currently expect revenues in 2025 to be US$3.39b, approximately in line with the last 12 months. Per-share earnings are expected to surge 44% to US$4.00. Before this earnings report, the analysts had been forecasting revenues of US$3.31b and earnings per share (EPS) of US$3.62 in 2025. There's been a pretty noticeable increase in sentiment, with the analysts upgrading revenues and making a nice gain to earnings per share in particular. Check out our latest analysis for PHINIA It will come as no surprise to learn that the analysts have increased their price target for PHINIA 11% to US$54.60on the back of these upgrades. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on PHINIA, with the most bullish analyst valuing it at US$65.00 and the most bearish at US$46.00 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation. Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. One thing stands out from these estimates, which is that PHINIA is forecast to grow faster in the future than it has in the past, with revenues expected to display 2.1% annualised growth until the end of 2025. If achieved, this would be a much better result than the 4.3% annual decline over the past year. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 13% annually for the foreseeable future. Although PHINIA's revenues are expected to improve, it seems that the analysts are still bearish on the business, forecasting it to grow slower than the broader industry. The Bottom Line The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around PHINIA's earnings potential next year. Fortunately, they also upgraded their revenue estimates, although our data indicates it is expected to perform worse than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time. Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple PHINIA analysts - going out to 2027, and you can see them free on our platform here. Plus, you should also learn about the 1 warning sign we've spotted with PHINIA . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
29 minutes ago
- Yahoo
Bread Financial Holdings (NYSE:BFH) Has Affirmed Its Dividend Of $0.21
The board of Bread Financial Holdings, Inc. (NYSE:BFH) has announced that it will pay a dividend on the 12th of September, with investors receiving $0.21 per share. This payment means the dividend yield will be 1.3%, which is below the average for the industry. While the dividend yield is important for income investors, it is also important to consider any large share price moves, as this will generally outweigh any gains from distributions. Investors will be pleased to see that Bread Financial Holdings' stock price has increased by 31% in the last 3 months, which is good for shareholders and can also explain a decrease in the dividend yield. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Bread Financial Holdings' Earnings Will Easily Cover The Distributions It would be nice for the yield to be higher, but we should also check if higher levels of dividend payment would be sustainable. Bread Financial Holdings has established itself as a dividend paying company, given its 9-year history of distributing earnings to shareholders. Using data from its latest earnings report, Bread Financial Holdings' payout ratio sits at 14%, an extremely comfortable number that shows that it can pay its dividend. Over the next 3 years, EPS is forecast to expand by 37.5%. Analysts forecast the future payout ratio could be 12% over the same time horizon, which is a number we think the company can maintain. View our latest analysis for Bread Financial Holdings Bread Financial Holdings' Dividend Has Lacked Consistency Even in its relatively short history, the company has reduced the dividend at least once. This suggests that the dividend might not be the most reliable. Since 2016, the annual payment back then was $2.08, compared to the most recent full-year payment of $0.84. Doing the maths, this is a decline of about 9.6% per year. Generally, we don't like to see a dividend that has been declining over time as this can degrade shareholders' returns and indicate that the company may be running into problems. The Dividend's Growth Prospects Are Limited Dividends have been going in the wrong direction, so we definitely want to see a different trend in the earnings per share. Although it's important to note that Bread Financial Holdings' earnings per share has basically not grown from where it was five years ago, which could erode the purchasing power of the dividend over time. Our Thoughts On Bread Financial Holdings' Dividend In summary, while it's good to see that the dividend hasn't been cut, we are a bit cautious about Bread Financial Holdings' payments, as there could be some issues with sustaining them into the future. The low payout ratio is a redeeming feature, but generally we are not too happy with the payments Bread Financial Holdings has been making. We would probably look elsewhere for an income investment. It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. Taking the debate a bit further, we've identified 2 warning signs for Bread Financial Holdings that investors need to be conscious of moving forward. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Brunswick Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Brunswick (NYSE:BC) Second Quarter 2025 Results Key Financial Results Revenue: US$1.45b (flat on 2Q 2024). Net income: US$59.6m (down 43% from 2Q 2024). Profit margin: 4.1% (down from 7.3% in 2Q 2024). EPS: US$0.90 (down from US$1.55 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Brunswick Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 15%. Earnings per share (EPS) missed analyst estimates by 7.5%. Looking ahead, revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Leisure industry in the US. Performance of the American Leisure industry. The company's shares are up 1.9% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Brunswick (1 is significant) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
